QA: Cellectar Biosciences Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2018_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 10,939,417
1 IntangibleAssetsNetIncludingGoodwill 1,675,462
2 PropertyPlantAndEquipmentNet 244,713
3 remainder_Assets 11,872
4 LiabilitiesCurrent 2,114,788
5 LiabilitiesNoncurrent 2,213
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,325,180
9 ResearchAndDevelopmentExpense 7,788,965
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -528,901
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,871,464
1 Liabilities 2,117,001
2 Expenses 12,114,145
3 Revenues 0
4 StockholdersEquity 10,754,463
5 NetIncome -12,643,046
6 ComprehensiveNetIncome -12,643,046
7 BaseVar 13,815,756
8 EconomicCapitalRatiobeforeLimitedLiability 1.44
9 EconomicCapitalRatio 2.64

Edgar->Model Mapping

Feature Distribution

Change over Time